Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-04-09
1993-06-15
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514314, 514450, A61K 3144, A61K 3147, A61K 31335
Patent
active
052198650
ABSTRACT:
The present invention relates to combinations of the malaria therapeutics artemisinine, dihydroartemisinine, arteether, artemether, artesunate or other artemisinine derivatives with one or more of the antimalarials chloroquine, 10-0-methylfloxacrine, quinine, mefloquine, amodiaquine, pyrimethamine, sulfadoxine and primaquine. Synergistic actions are achieved with them on treatment of mammals, including humans, with subcurative doses of the individual substances.
REFERENCES:
patent: 4260615 (1981-04-01), Raether et al.
patent: 4791135 (1988-12-01), Lin et al.
Chemical Abstracts 97:16656g (1982).
Chemical Abstracts 108:112772h (1988).
R. Ekong et al., "Synergism Between Arteether And Mefloquine Or Quinine In A Multidrug-resistant Strain Of Plasmodium Falciparum In Vitro," Transactions of the Royal Society of Tropical Medicine and Hygiene, 84:757-758 (1990).
A. N. Chawira et al., "The Effect Of Artemisinin Combined With Standard Antimalarials Against Chloroquine-Sensitive And Chloroquine-Resistant Strains of Plasmodium-Falciparum In-vitro," J. Trop. Med. Hyg., 90(1):1-8 (1987) Abstract only.
Y. D. Wan et al., "Study On The Combined Use Of Artemisinine And Primaquine Against Short-Term Malarial Relapse," Yao Hsueh T'ung Pao, 16(1):9-12, 14, (1981) Abstract only.
J. X. Zhang et al., "A Combined Regimen Of Pyronaridin-Artemether-Chloroquine (PAC) For The Treatment Of Plasmodium Cynomoigi In The Rhesus Monkey," Yao Hsueh Hsueh Pao, 19(8):571-575 (Aug. 1984) Abstract only.
G. Li et al., "Randomised Comparative Study Of Mefloquine, Qinghaosu, And Pyrimethamine-Sulfadoxine In Patients With Falciparum Malaria," Lancet (England), 2(8416):1360-1361 (1984) Abstract only.
Tropical Disease Research, Seventh Programme Report, Chapter 2, Malaria, UNDP/WORLD BANK/WHO published by the WHO in 1985 Warhurst, D.C., "Drug Resistance", Pharmaceutical J., Nov. 23 (1985) 689-692.
Nathan, M. B., "A comparison of Mansonella ozzardi microfilaria densities in the blood and in skin snips from three areas of the body", Trans. R. Soc., Trop. Med. and Hyg., 73 (3), 338-340 (1983).
Merkli et al., "The Inhibitory Effect of a Drug Combination on the Development of Mefloquine Resistance in Plaasmodium", Annals of Tropical Medicine and Parasitology 74, No. 1: 1-9 (1980).
H. P. Koch, "Qinghaosu: A Potent Antimalarial From Plant Origin", Pharm. Int. 184-185 (1981).
L. J. Bruce-Chwatt, "Qinghaosu: A New Antimalarial", British Med. J. 284: 767-768.
Peters, et al., "The Chemotherapy of Rodent Malaria, XXVII, Studies on Mefloquine", Annals of Tropical Medicine & Parasitology 71, No. 4: 407-418 (1977).
W. Peters, "Prevention of Drug Resistance in Rodent Malaria by the use of Drug Mixtures", Bull W.H.O. 51: 379-383 (1974).
Peters, et al. "Antimalarial Drugs II", Handbook of Experimental Pharmacology 68/11 (1984) Springer Verlag Berlin, Heidelberg, New York, Editors: W. Peters and W. H. G. Richards.
Table of Contents of W.H. O. Report of the Scientific Working Group on the Chemotherapy of Malaria, PDR/Chemal 3rd Review, 85.3 Geneva, Jun. 3-5, 1985.
Raether and Fink, "Antimalarial activity of Floxacrine (HOE 991)I Ann. Trop. Med. and Parasit.", 73, No. 6: 505-526 (1979).
Chatterjee Dipak C.
de Souza Noel J.
Lal Bansi
Rupp Richard H.
Venugopalan Bindumadhavan
Finnegan, Henderson Farabow, Garrett & Dunner
Goldberg Jerome D.
Hoechst Aktiengesellschaft
LandOfFree
Pharmaceutical combination for the prophylaxis and therapy of ma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical combination for the prophylaxis and therapy of ma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical combination for the prophylaxis and therapy of ma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1042925